Literature DB >> 8280090

Kinetics of the inhibition of human factor Xa by full-length and truncated recombinant tissue factor pathway inhibitor.

T Lindhout1, G Willems, R Blezer, H C Hemker.   

Abstract

The inhibition equilibrium and kinetics of association and dissociation of the binding of three types of recombinant tissue factor pathway inhibitor (TFPI), namely full-length TFPI, C-terminal-truncated TFPI, and TFPI without the third Kunitz domain (TFPI1-161), to factor Xa have been measured. Formation and dissociation of the complexes were monitored by continuous measurement of the changes in the rate of hydrolysis of a peptidyl-p-nitroanilide substrate. Progress curves of product formation were fitted to a set of equations describing a one-step bimolecular inhibitory reaction in the presence of a competing substrate. For full-length TFPI the rate constants of association (kon) and dissociation (koff) were (5.1 +/- 0.7) x 10(6) M-1.s-1 and (2.6 +/- 0.9) x 10(-4)s-1 respectively. Thus, although the inhibition constant (50 pM) is far below the plasma concentration (2.5 nM) of TFPI, the half-time for transition to equilibrium in plasma is rather long (66s). The truncated forms of TFPI differ in that they have a 4-fold lower kon value but a similar dissociation rate constant. Therefore the inhibition constant, Ki, is 4-fold higher (0.2 nM) and the half-time to achieve equilibrium is prolonged to 250 s. The kon values of full-length and C-terminal-truncated TFPI, but not that of TFPI1-161, were found to decrease with increasing ionic strength.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8280090      PMCID: PMC1137801          DOI: 10.1042/bj2970131

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  20 in total

1.  Tight-binding inhibitors-I. Kinetic behavior.

Authors:  S Cha
Journal:  Biochem Pharmacol       Date:  1975-12-01       Impact factor: 5.858

2.  Characterization of the inhibition of tissue factor in serum.

Authors:  G J Broze; J P Miletich
Journal:  Blood       Date:  1987-01       Impact factor: 22.113

Review 3.  Tissue factor and hemostasis.

Authors:  Y Nemerson
Journal:  Blood       Date:  1988-01       Impact factor: 22.113

4.  1-Aminocyclopropanephosphonate: time-dependent inactivation of 1-aminocyclopropanecarboxylate deaminase and Bacillus stearothermophilus alanine racemase by slow dissociation behavior.

Authors:  M D Erion; C T Walsh
Journal:  Biochemistry       Date:  1987-06-16       Impact factor: 3.162

5.  The limited importance of factor Xa inhibition to the anticoagulant property of heparin in thromboplastin-activated plasma.

Authors:  J Pieters; T Lindhout
Journal:  Blood       Date:  1988-12       Impact factor: 22.113

Review 6.  The behavior and significance of slow-binding enzyme inhibitors.

Authors:  J F Morrison; C T Walsh
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1988

Review 7.  Protein inhibitors of proteinases.

Authors:  M Laskowski; I Kato
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

8.  The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action.

Authors:  G J Broze; L A Warren; W F Novotny; D A Higuchi; J J Girard; J P Miletich
Journal:  Blood       Date:  1988-02       Impact factor: 22.113

9.  Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation.

Authors:  L V Rao; S I Rapaport
Journal:  Blood       Date:  1987-02       Impact factor: 22.113

10.  Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains.

Authors:  T C Wun; K K Kretzmer; T J Girard; J P Miletich; G J Broze
Journal:  J Biol Chem       Date:  1988-05-05       Impact factor: 5.157

View more
  8 in total

1.  Prothrombinase is protected from inactivation by tissue factor pathway inhibitor: competition between prothrombin and inhibitor.

Authors:  J Franssen; I Salemink; G M Willems; T C Wun; H C Hemker; T Lindhout
Journal:  Biochem J       Date:  1997-04-01       Impact factor: 3.857

2.  Glypican-3 is a binding protein on the HepG2 cell surface for tissue factor pathway inhibitor.

Authors:  A E Mast; D A Higuchi; Z F Huang; I Warshawsky; A L Schwartz; G J Broze
Journal:  Biochem J       Date:  1997-10-15       Impact factor: 3.857

3.  Gla-domainless factor Xa: molecular bait to bypass a blocked tenase complex.

Authors:  Raphaël Marlu; Benoît Polack
Journal:  Haematologica       Date:  2012-04-04       Impact factor: 9.941

4.  Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor.

Authors:  Tilman M Hackeng; Kristin M Seré; Guido Tans; Jan Rosing
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-17       Impact factor: 11.205

5.  Small peptides blocking inhibition of factor Xa and tissue factor-factor VIIa by tissue factor pathway inhibitor (TFPI).

Authors:  Michael Dockal; Rudolf Hartmann; Markus Fries; M Christella L G D Thomassen; Alexandra Heinzmann; Hartmut Ehrlich; Jan Rosing; Frank Osterkamp; Thomas Polakowski; Ulrich Reineke; Andreas Griessner; Hans Brandstetter; Friedrich Scheiflinger
Journal:  J Biol Chem       Date:  2013-11-25       Impact factor: 5.157

6.  TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain.

Authors:  Natalia Reglińska-Matveyev; Helena M Andersson; Suely M Rezende; Björn Dahlbäck; James T B Crawley; David A Lane; Josefin Ahnström
Journal:  Blood       Date:  2014-04-16       Impact factor: 22.113

7.  Comparison of the inhibitory activities of human tissue factor pathway inhibitor (TFPI)α and TFPIβ.

Authors:  S A Maroney; P E Ellery; J P Wood; J P Ferrel; N D Martinez; A E Mast
Journal:  J Thromb Haemost       Date:  2013-05       Impact factor: 5.824

8.  A novel assay based on pre-equilibrium titration curves for the determination of enzyme inhibitor binding kinetics.

Authors:  Bernard Noppen; Anouk Vanbelle; Alan W Stitt; Marc Vanhove
Journal:  Eur Biophys J       Date:  2021-06-22       Impact factor: 1.733

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.